falsefalse

Advancements in the Treatment of Desmoid Tumors - Episode 3

Signs and Symptoms of Desmoid Tumors and Their Impact on Quality of Life

, , ,

Mark Agulnik, MD, discusses signs and symptoms commonly presenting with desmoid tumors and their impact on quality of life for patients.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: An Overview of the Landscape Surrounding Desmoid Tumors
    EP. 2: Expert Perspectives on the Pathogenesis and Diagnosis of Desmoid Tumors
    Now Viewing
    EP. 3: Signs and Symptoms of Desmoid Tumors and Their Impact on Quality of Life
    EP. 4: Active Surveillance in Frontline Management of Desmoid Tumors
    EP. 5: The Evolving Role of Surgery in the Management of Desmoid Tumors
    EP. 6: Treatment Strategies Using Radiotherapy or Other Locoregional Approaches in Desmoid Tumors
    EP. 7: Approaches to Systemic Therapy in Desmoid Tumors: The Role of Chemotherapy
    EP. 8: The Role of Supportive Care Measures in Patients with Desmoid Tumors
    EP. 9: Desmoid Tumors in Women: Special Considerations for Pregnancy and Contraception
    EP. 10: Targeting NOTCH Pathway Signaling with Nirogacestat
    EP. 11: DeFi: Nirogacestat in Patients with Progressing Desmoid Tumors
    EP. 12: Impact of Nirogacestat on Pain, Quality of Life, and Fertility in Patients with Desmoid Tumors
    EP. 13: Nirogacestat's Impact on the Future Treatment of Desmoid Tumors
    EP. 14: Future Perspectives on the Treatment of Desmoid Tumors

    Related Content:

    Advancements in the Treatment of Desmoid TumorsOncLive Peer Exchange®
    Insights From Liso-cel Combined With Ibr for R/RCLL/SLL: Primary Results From the Open-Label, Phase 1/2 Transcend CLL 004 Study
    Overview of the Fixed-Duration Epcoritamab + R-Mini-CHOP in Patients With Previously Untreated DLBCL Ineligible for Full-Dose R-CHOP: Updated Results from Arm 8 of the Epcore NHL-2 Trial
    Balancing Cure and Toxicity: Tailoring AlloHSCT Intensity and Timing
    x